Literature DB >> 18642017

Triamcinolone acetonide for refractory pseudophakic cystoid macular edema after intravitreal bevacizumab.

María Rodríguez-Blanco, Joaquin Marticorena, Francisco Gómez-Ulla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18642017     DOI： 10.1007/s00417-008-0897-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  8 in total

Review 1.  The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.

Authors:  A J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; Andrew A Moshfeghi; Carmen A Puliafito
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2005 Jul-Aug

3.  [Intravitreal injection of bevacizumab for pseudophakic cystoid macular edema resistant to steroids].

Authors:  M Díaz-Llopis; L Amselem; E Cervera; S García-Delpech; C Torralba; J Montero
Journal:  Arch Soc Esp Oftalmol       Date:  2007-07

4.  Increased intraocular pressure induced by repository corticosteroids.

Authors:  J Herschler
Journal:  Am J Ophthalmol       Date:  1976-07       Impact factor: 5.258

5.  Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema.

Authors:  John O Mason; Michael A Albert; Rachel Vail
Journal:  Retina       Date:  2006-03       Impact factor: 4.256

6.  Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema.

Authors:  Martin S Spitzer; Focke Ziemssen; Efdal Yoeruek; Katrin Petermeier; Sabine Aisenbrey; Peter Szurman
Journal:  J Cataract Refract Surg       Date:  2008-01       Impact factor: 3.351

7.  Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease.

Authors:  Yoko Matsumoto; K Bailey Freund; Enrico Peiretti; Michael J Cooney; Daniela C A C Ferrara; Lawrence A Yannuzzi
Journal:  Retina       Date:  2007 Apr-May       Impact factor: 4.256

8.  Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema: pilot study of the Pan-American Collaborative Retina Study Group.

Authors:  J Fernando Arevalo; Rafael A Garcia-Amaris; Jose A Roca; Juan G Sanchez; Lihteh Wu; Maria H Berrocal; Mauricio Maia
Journal:  J Cataract Refract Surg       Date:  2007-12       Impact factor: 3.351
  8 in total
  1 in total

1.  Perioperative Management of Uveitic Cataracts.

Authors:  Judy L Chen; Pooja Bhat; Ann-Marie Lobo-Chan
Journal:  Adv Ophthalmol Optom       Date:  2019-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.